Background: Immune-mediated inflammatory diseases predispose to a higher infection risk by modifying the host's immune response, which acts as a key factor in SARS-CoV-2 infection resolution . Recent publications show that IMID patients and its treatments do not worsen the outcome of SARS-CoV-2 infection.
Objectives: To describe the clinical characteristics and outcomes of patients with IMID who required hospital admission due to SARS-CoV-2 infection . Secondly, to compare clinical characteristics and outcomes between patients who required hospital admission due to SARS-CoV-2 infection with IMID and those who were not affected.Methods: We performed an observational retrospective cohort study, including admitted patients with suspected SARS-CoV-2 infection, treated according to medical criteria and local protocols based on the best available scientific evidence . Clinical data were collected from their electronical clinical history . Statistical analysis determined the differences in the characteristics and clinical outcome of the infection in IMID patients.Results: Of a total number of 612 revised patients, 23 had an IMID and 9 of them were positive for the SARS-CoV-2 infection . We did not observe a correlation between these two disorders . There was a higher frequency of obesity and cardiovascular disease among IMID patients, but without statistical significance . The clinical outcomes were no different between hospitalized IMID and non IMID patients.
Conclusions: IMID and its treatments do not determine the outcome of patients admitted with SARS-CoV-2 infection.